Ethic Inc’s Charles River Laboratories CRL Stock Holding History

Ethic Inc’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$706K	Sell	3,113 -1,491	-32%	-$266K	0.01%	822
2026 Q1	$794K	Sell	4,604 -791	-15%	-$147K	0.01%	721
2025 Q4	$1.08M	Buy	5,395 +47	+0.9%	+$8.53K	0.02%	621
2025 Q3	$837K	Sell	5,348 -2,072	-28%	-$329K	0.01%	685
2025 Q2	$1.11M	Buy	7,420 +3,836	+107%	+$512K	0.02%	589
2025 Q1	$523K	Buy	+3,584	New	+$601K	0.01%	773
2024 Q4	–	Sell	-953	Closed	-$258K	–	1171
2024 Q3	$258K	Sell	953 -105	-10%	-$21.8K	0.01%	927
2024 Q2	$219K	Buy	1,058 +105	+11%	+$23.8K	0.01%	1009
2024 Q1	$258K	Buy	+953	New	+$228K	0.01%	924
2022 Q3	–	Sell	-2,730	Closed	-$584K	–	807
2022 Q2	$584K	Sell	2,730 -974	-26%	-$238K	0.04%	435
2022 Q1	$1.05M	Buy	3,704 +2,006	+118%	+$619K	0.07%	303
2021 Q4	$640K	Sell	1,698 -82	-5%	-$31.9K	0.05%	356
2021 Q3	$735K	Sell	1,780 -189	-10%	-$78.5K	0.08%	279
2021 Q2	$728K	Buy	1,969 +821	+72%	+$274K	0.09%	270
2021 Q1	$333K	Buy	+1,148	New	+$319K	0.06%	356

Other funds holding CRL

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

LKIM

Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Ethic Inc's CRL Position: Q2 2026 in Review

Ethic Inc reduced its Charles River Laboratories (CRL) stake by 32% in Q2 2026, selling an estimated $266K and leaving 3,113 shares worth $706K. The position accounts for 0.01% of the portfolio, ranked #822.

Ethic Inc first reported a position in CRL in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.11M in Q2 2025. 150 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Ethic Inc held 3,113 shares of Charles River Laboratories worth $706K as of Q2 2026.
Ethic Inc sold 1,491 Charles River Laboratories shares in Q2 2026, an estimated $266K.
Charles River Laboratories made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #822 holding.
Ethic Inc first reported a position in Charles River Laboratories in Q1 2021 and has held it in 15 quarters since.
Ethic Inc's Charles River Laboratories position peaked at $1.11M in Q2 2025.
150 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.